Allegra-D no longer is on the outside looking in at the OTC pseudoephedrine-containing antihistamine competition as FDA approves adding “relief of nasal congestion due to the common cold” to the Sanofi product label.
While Claritin-D, Zyrtec-D and generic versions of those brands have included the indication on labels since FDA approved each product,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?